A Study of Two Dosage Forms of LY2886721 in Healthy Participants
PHASE1
The purpose of this study is to evaluate two different formulations of LY28...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Single Dose Study in Healthy Participants to Investigate the Safety and Absorption of LY2584702
PHASE1
This is a single-centre, placebo-controlled, two-part study in healthy part...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.